December 4, 2025

Our 2020-2024 Long-Term Strategic Plan: Guiding Meaningful Progress

Over the past several years, we’ve driven important progress — from expanding access to CFTR modulators to advancing genetic therapies. As we prepare to launch our next strategic plan in 2026, we remain committed to our mission: helping people with cystic fibrosis live longer, fuller lives, and ultimately, delivering a cure for all. 

Read the highlights »

Join our North American Cystic Fibrosis Conference (NACFC) Highlights Webinar With Q+A 

Interested in learning about the latest CF research and care highlights from NACFC? Join us live, Dec. 10 at 7 p.m. ET to hear key takeaways from this year’s conference and have an opportunity to ask the experts your questions. 

Register now »

Now Enrolling: Genetic Therapy Clinical Trials For People With CF

Do you want to help advance cystic fibrosis research? Multiple clinical trials testing genetic therapies for CF are underway, and if you do not benefit from CFTR modulators, you may qualify to participate. Visit the Clinical Trial Finder to learn more about trials enrolling now.  

Sign up for a clinical trial today »

Learn About Lung Transplant Centers

If you are considering a lung transplant or learning how to maintain your health after a transplant, you can access important information about transplant centers, including how many transplants they’ve performed in the past six years — overall and for people with cystic fibrosis.

Find a lung transplant center »

From the Community Blog: Giving Voice to Those Without Modulators

The REACH Study  — REsearch to Advance the CF THerapeutics Pipeline for People without Modulators —  aims to help advance new therapies for all people with cystic fibrosis who do not take CFTR modulators, regardless of their reason. In our latest blog, five members of our community share how their personal experiences have motivated them to contribute to REACH and why it matters for the future of CF care. 

Read the full blog »